Trials / Completed
CompletedNCT00467506
Phase II Two-step Radioimmunotherapy Clinical Study in Medullary Thyroid Carcinoma
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Nantes University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Phase II clinical trial assessing efficacy and toxicity of pretargeted radioimmunotherapy using anti-CEAxanti-DTPA bispecific antibody and di-DTPA-131I peptide in patients with reccurrence of medullary thyroid carcinoma (abnormal calcitonin level and biomarkers doubling time lower than 5 years)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | bispecific antibody and di-DTPA-131I |
Timeline
- Start date
- 2004-05-01
- Primary completion
- 2011-01-01
- Completion
- 2011-01-01
- First posted
- 2007-04-30
- Last updated
- 2011-11-11
Locations
11 sites across 1 country: France
Source: ClinicalTrials.gov record NCT00467506. Inclusion in this directory is not an endorsement.